- News & Media
Tikcro develops its drug candidates in collaboration with research centers and pharmaceutical contracting partners.
Our strategy is to establish product development, pre clinical and discovery collaborations. These collaborations supplement our corporate and business capabilities, to advance our pipeline and validate our technology.
Product in Development
CTLA-4 Antibody for immune oncology
PD1 Antibody for immune oncology